Hyperbaric oxygen therapy and age-related macular degeneration
Volume: 37, Issue: 2, Pages: 101 - 105
Published: Mar 1, 2010
Abstract
Age-related macular degeneration (AMD) is a significant cause of visual loss in the United States and Western Europe. As the population ages, the prevalence rate of advanced AMD is expected to double by 2030. A one-hour session of hyperbaric oxygen therapy (HBO2) was used to treated a group of 14 patients with advanced AMD. Eight patients were treated at 1.75 ATA, and six patients were treated at 1.5 ATA for one hour. Significant improvements in...
Paper Details
Title
Hyperbaric oxygen therapy and age-related macular degeneration
Published Date
Mar 1, 2010
Volume
37
Issue
2
Pages
101 - 105
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History